On May 14, 2019 Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, reported that members of the management team will provide a business overview and update at the 2019 RBC Capital Markets Global Healthcare Conference at 9:30 am ET on Tuesday, May 21, 2019 and at the UBS Global Healthcare Conference at 10:00 am ET on Wednesday, May 22, 2019, both in New York, NY (Press release, Alder Biopharmaceuticals, MAY 14, 2019, View Source [SID1234536343]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The presentations will be webcast live on the Events & Presentations page of the Investors section of Alder’s website at View Source, or by following the links below in your web browser. An archived replay of each webcast will be available on Alder’s website for at least 30 days after each live event concludes.
RBC:http://www.veracast.com/webcasts/rbc/healthcare2019/15314267548.cfm
UBS: https://cc.talkpoint.com/ubsx001/052019a_as/?entity=49_QLELLE8